arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

IDEAYA Biosciences, Inc.

IDYA Health Care Biotechnology: Pharmaceutical Preparations
$28.29
▼ -3.2% Today
as of Jun 7, 07:17 ET
Last 30 days -2.58% Apr 28 → Jun 05
$27.73 $28.24 $28.76 $29.28 $29.79 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$29.22
High
$29.59
Low
$28.19
Volume
$688,885
Avg Vol
$1M
Mkt Cap
$2.6B
P/E (TTM)
Beta
52w High
$39.28
52w Low
$20.45
Div Yield
Shares Out
$88M

Overview

52-week range
$20
$39
42% of range
Avg surprise (last 2)
-6.5%
Avg reaction (last 2)
-6.8%
0% positive
Latest IV / EM
41%
EM ±5.7% · $28 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.11$-0.50$0.11$0.72$1.33 Actual $-0.50Actual $-0.46Actual $-0.53Actual $-0.68Actual $-0.60Actual $-0.82Est $-0.75Actual $-0.88Actual $1.33Actual $-1.11Est $-1.07 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-99M$-19M$60M$139M$218M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-1.11 $-1.07 -3.7% -35.4% -0.3% earnings
Tue Sep 30, 2025Sep 2025 $1.33 financials
Mon Jun 30, 2025Jun 2025 $-0.88 financials
Tue May 6, 2025Mar/2025 $-0.82 $-0.75 -9.3% -13.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.60 financials
Sun Jun 30, 2024Jun 2024 $-0.68 financials
Sun Mar 31, 2024Mar 2024 $-0.53 financials
Sat Sep 30, 2023Sep 2023 $-0.46 financials
Fri Jun 30, 2023Jun 2023 $-0.50 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$7M$208M$0$0
Cost of revenue
Gross profit
Operating income$-109M$108M$-89M$-84M$-67M$-65M
Net income$-99M$119M$-77M$-72M$-52M$-53M
EPS (diluted)$-1.11$1.33$-0.88$-0.82$-0.60$-0.68

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$158M$113M$299M$115M$130M$84M$400M$183M
Inventory
Total current assets$696M$667M$803M$686M$708M$690M$932M$713M
Total assets$1.03B$1.11B$1.19B$1.04B$1.10B$1.12B$1.24B$974M
Long-term debt
Total liabilities$93M$86M$93M$82M$77M$65M$59M$42M
Total equity$937M$1.02B$1.09B$960M$1.02B$1.06B$1.18B$932M

Implied volatility — last 90 days

35%38%40%43%45% Jun 07 — IV 41% · EM ±5.7%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.